Short Message Service (SMS) Reminders for Stroke Secondary Preventative Medications
The Use of Short Message Service (SMS) as a Reminder for Continuation of Treatment With Secondary Preventative Medications After Stroke or TIA
1 other identifier
interventional
10
1 country
1
Brief Summary
Secondary preventative medications are prescribed to reduce the risk of recurrent stroke following ischaemic stroke. However, continuation rates can be as low as 50% and are likely to be multifactorial. One factor will be patients forgetting to take the medication or a reduced appreciation of the importance of the medication as the time from the stroke passes. Numerous approaches to improve persistence to secondary preventative medications have been tried. One simple approach is use of mobile phone text messages as a reminder for patients to take their medications. In this study, we will introduce an educational and motivational strategy to inform patients about their medications and explore whether a reminder intervention, using Short Message Service (SMS), improves adherence to antiplatelet drugs, antihypertensive medications and lipid lowering drugs. We will also explore whether this improves blood pressure and cholesterol levels in the first 3 months after stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Jan 2015
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 8, 2015
CompletedFirst Posted
Study publicly available on registry
January 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFebruary 1, 2016
January 1, 2016
9 months
January 8, 2015
January 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence rate to stroke secondary preventative medication
Morisky Medication Adherence Scale (MMAS) - 8 items
3 months
Secondary Outcomes (2)
Effect of medication adherence on clinical outcomes
3 months
Effect of medication adherence on clinical outcomes
3 months
Study Arms (2)
SMS reminder
EXPERIMENTALDaily SMS medication reminder
No SMS reminder
NO INTERVENTIONNo daily SMS medication reminder
Interventions
Eligibility Criteria
You may qualify if:
- diagnosed with stroke or TIA
- treated with any combination of anti-platelet, antihypertensive, and/or lipid-modifying drugs; at least one of which started over the past month
- living in the community
You may not qualify if:
- severe disability (modified Rankin Scale (mRS) ≥ 4)
- patients unable to consent
- patients with no facility to be reminded by SMS or voicemail message
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
Study Sites (1)
Western Infirmary, NHS Greater Glasgow and Clyde
Glasgow, G11 6NT, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jesse Dawson, BSc MBChB MD
University of Glasgow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2015
First Posted
January 13, 2015
Study Start
January 1, 2015
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
February 1, 2016
Record last verified: 2016-01